Katya Tsaioun

1.6k total citations · 1 hit paper
34 papers, 776 citations indexed

About

Katya Tsaioun is a scholar working on Small Animals, Statistics, Probability and Uncertainty and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Katya Tsaioun has authored 34 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Small Animals, 7 papers in Statistics, Probability and Uncertainty and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Katya Tsaioun's work include Animal testing and alternatives (8 papers), Meta-analysis and systematic reviews (7 papers) and Computational Drug Discovery Methods (6 papers). Katya Tsaioun is often cited by papers focused on Animal testing and alternatives (8 papers), Meta-analysis and systematic reviews (7 papers) and Computational Drug Discovery Methods (6 papers). Katya Tsaioun collaborates with scholars based in United States, Germany and United Kingdom. Katya Tsaioun's co-authors include Aloı̈se Mabondzo, Michel Bottlaender, Karina W. Davidson, Bruno O. Villoutreix, Natesh Singh, Philippe Vayer, Jean‐Luc Poyet, Roger J. Hajjar, Judith K. Gwathmey and R. R. Annand and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and Nature Reviews Drug Discovery.

In The Last Decade

Katya Tsaioun

34 papers receiving 747 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug discovery and development: introduction to the general public and patient groups

2023 98 citations Natesh Singh, Philippe Vayer et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by Katya Tsaioun

Since Specialization

Citations

This map shows the geographic impact of Katya Tsaioun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katya Tsaioun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katya Tsaioun more than expected).

Fields of papers citing papers by Katya Tsaioun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katya Tsaioun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katya Tsaioun. The network helps show where Katya Tsaioun may publish in the future.

Co-authorship network of co-authors of Katya Tsaioun

This figure shows the co-authorship network connecting the top 25 collaborators of Katya Tsaioun. A scholar is included among the top collaborators of Katya Tsaioun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katya Tsaioun. Katya Tsaioun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GRADE guidance 40: The GRADE evidence-to-decision framework for environmental and occupational health 2025 ·Environment International ·Emily Senerth, Paul Whaley, Elie A. Akl, Brandy Beverly, Pablo Alonso‐Coello, Andrew A. Rooney, Holger J. Schünemann, Kristina A. Thayer, Katya Tsaioun, Rebecca L. Morgan	2
2	The effects of radiofrequency electromagnetic field exposure on biomarkers of oxidative stress in vivo and in vitro: A systematic review of experimental studies 2024 ·Environment International ·Felix Meyer, Annette Bitsch, Henry Jay Forman, Athanassios Fragoulis, Pietro Ghezzi, (unknown), Rupert Kellner, Jens Kühne, Tonia Ludwig, (unknown), Gernot Schmid, Katya Tsaioun, Jos Verbeek, Robert A. Wright	14
3	Development of a framework to structure decision-making in environmental and occupational health: A systematic review and Delphi study 2024 ·Environment International ·Emily Senerth, Paul Whaley, Elie A. Akl, Brandy Beverly, Pablo Alonso‐Coello, (unknown), (unknown), (unknown), Andrew A. Rooney, Holger J. Schünemann, Kristina A. Thayer, Katya Tsaioun, Rebecca L. Morgan	4
4	60 Years of the 3Rs symposium: Lessons learned and the road ahead 2024 ·ALTEX ·Michael Balls, (unknown), (unknown), Julia H. Fentem, Alan M. Goldberg, Thomas Härtung, Kathrin Herrmann, Nicole Kleinstreuer, (unknown), John Parascandola, Andrew Rowan, Horst Spielmann, Martin L. Stephens, Russell S. Thomas, Katya Tsaioun	3
5	Systematic review methods in environmental health: a critical interpretive synthesis to inform the evolution of systematic review guidance 2024 ·Zenodo (CERN European Organization for Nuclear Research) ·Emily Senerth, (unknown), (unknown), (unknown), Paul Whaley, (unknown), Katya Tsaioun, Rebecca L. Morgan	1
6	Drug discovery and development: introduction to the general public and patient groups breakdown → 2023 ·SHILAP Revista de lepidopterología ·Natesh Singh, Philippe Vayer, (unknown), Jean‐Luc Poyet, Katya Tsaioun, Bruno O. Villoutreix	98
7	Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example 2022 ·International Journal of Radiation Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Katya Tsaioun, Carole L. Yauk, Ruth C. Wilkins, Vinita Chauhan	8
8	Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity 2022 ·Current Research in Toxicology ·Aldert H. Piersma, Nancy Baker, George P. Daston, Burkhard Flick, Michio Fujiwara, Thomas B. Knudsen, Horst Spielmann, Noriyuki Suzuki, Katya Tsaioun, Hajime Kojima	13
9	Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: A case for ARDS therapy development 2022 ·Drug Discovery Today ·Usamah S. Kayyali, (unknown), Natesh Singh, Bruno O. Villoutreix, Katya Tsaioun	2
10	Biological plausibility in environmental health systematic reviews: a GRADE concept paper 2022 ·Environment International ·Paul Whaley, Thomas Piggott, Rebecca L. Morgan, Sebastian Hoffmann, Katya Tsaioun, Lukas Schwingshackl, Mohammed Ansari, Kristina A. Thayer, Holger J. Schünemann	9
11	A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides 2022 ·Data in Brief ·(unknown), Patrick Auberger, Germain Gillet, Mario DiPaola, Katya Tsaioun, Bruno O. Villoutreix	5
12	Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review 2021 ·Scientific Reports ·Hubert Dirven, Gunn Elisabeth Vist, Sricharan Bandhakavi, Jyotsna Mehta, (unknown), Pandora Pound, (unknown), (unknown), Cathalijn H. C. Leenaars, Minjun Chen, Robert A. Wright, Katya Tsaioun	44
13	A primer on systematic reviews in toxicology 2017 ·Archives of Toxicology ·Sebastian Hoffmann, Rob B.M. de Vries, Martin L. Stephens, Nancy B. Beck, Hubert Dirven, (unknown), Julie E. Goodman, Thomas Härtung, Ian Kimber, Manoj M. Lalu, Kristina A. Thayer, Paul Whaley, Daniele Wikoff, Katya Tsaioun	57
14	Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods 2016 ·ALTEX ·Katya Tsaioun	91
15	Optimizing the use of CROs by academia and small companies 2013 ·Nature Reviews Drug Discovery ·Rachel Lane, Lauren G. Friedman, Curtis T. Keith, Steven P. Braithwaite, Julie A. Frearson, (unknown), Frank M. Longo, Lorenzo M. Refolo, D. Martin Watterson, Katya Tsaioun, Diana W. Shineman, Howard Fillit	2
16	QSAR-based permeability model for drug-like compounds 2011 ·Bioorganic & Medicinal Chemistry ·Rafael Gozalbes, (unknown), R. R. Annand, Katya Tsaioun, Antonio Pineda‐Lucena	42
17	Vitamin K-dependent Proteins in the Developing and Aging Nervous System 2009 ·Nutrition Reviews ·Katya Tsaioun	10
18	Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates 2009 ·Expert Opinion on Drug Metabolism & Toxicology ·Judith K. Gwathmey, Katya Tsaioun, Roger J. Hajjar	41
19	ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective 2009 ·BMC Neurology ·Katya Tsaioun, Michel Bottlaender, Aloı̈se Mabondzo	77
20	Response of vitamin K status to varied intakes of phylloquinone 1997 ·The FASEB Journal ·Sarah L. Booth, (unknown), Karina W. Davidson, Katya Tsaioun, James A. Sadowski	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact